Evidence map›Paper›PMID 28399797›Full record

ArticleBMC bioinformatics2017

A machine learning approach for viral genome classification.

Mohamed Amine Remita, Ahmed Halioui, Abou Abdallah Malick Diouara, Bruno Daigle, Golrokh Kiani, Abdoulaye Baniré Diallo

Abstract read
In one paragraph

Article in BMC bioinformatics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. SARS-CoV-2 virus classification based on stacked sparse autoencoder.Computational and structural biotechnology journal · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohamed Amine RemitaLaboratoire de bioinformatique, département d'informatique, Université du Québec à Montréal, Montreal, P.O. Box 8888 Downtown Station, H3C 3P8, Qc, Canada.
Ahmed HaliouiLaboratoire de bioinformatique, département d'informatique, Université du Québec à Montréal, Montreal, P.O. Box 8888 Downtown Station, H3C 3P8, Qc, Canada.
Abou Abdallah Malick DiouaraLaboratoire de bioinformatique, département d'informatique, Université du Québec à Montréal, Montreal, P.O. Box 8888 Downtown Station, H3C 3P8, Qc, Canada.
Bruno DaigleLaboratoire de bioinformatique, département d'informatique, Université du Québec à Montréal, Montreal, P.O. Box 8888 Downtown Station, H3C 3P8, Qc, Canada.
Golrokh KianiLaboratoire de bioinformatique, département d'informatique, Université du Québec à Montréal, Montreal, P.O. Box 8888 Downtown Station, H3C 3P8, Qc, Canada.
Abdoulaye Baniré DialloLaboratoire de bioinformatique, département d'informatique, Université du Québec à Montréal, Montreal, P.O. Box 8888 Downtown Station, H3C 3P8, Qc, Canada. diallo.abdoulaye@uqam.ca.ORCID http://orcid.org/0000-0002-1168-9371

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdvances in cloning and sequencing technology are yielding a massive number of viral genomes. The classification and annotation of these genomes constitute important assets in the discovery of genomic variability, taxonomic characteristics and disease mechanisms. Existing classification methods are often designed for specific well-studied family of viruses. Thus, the viral comparative genomic studies could benefit from more generic, fast and accurate tools for classifying and typing newly sequenced strains of diverse virus families.

resultsHere, we introduce a virus classification platform, CASTOR, based on machine learning methods. CASTOR is inspired by a well-known technique in molecular biology: restriction fragment length polymorphism (RFLP). It simulates, in silico, the restriction digestion of genomic material by different enzymes into fragments. It uses two metrics to construct feature vectors for machine learning algorithms in the classification step. We benchmark CASTOR for the classification of distinct datasets of human papillomaviruses (HPV), hepatitis B viruses (HBV) and human immunodeficiency viruses type 1 (HIV-1). Results reveal true positive rates of 99%, 99% and 98% for HPV Alpha species, HBV genotyping and HIV-1 M subtyping, respectively. Furthermore, CASTOR shows a competitive performance compared to well-known HIV-1 specific classifiers (REGA and COMET) on whole genomes and pol fragments.

conclusionThe performance of CASTOR, its genericity and robustness could permit to perform novel and accurate large scale virus studies. The CASTOR web platform provides an open access, collaborative and reproducible machine learning classifiers. CASTOR can be accessed at http://castor.bioinfo.uqam.ca .

Indexed as

Genome, ViralMachine LearningClassificationComputer SimulationGenomicsHepatitis B virusHIV-1HumansPapillomaviridaeSequence Analysis, DNASequence Analysis, RNAPredictionSequence classificationVirus classification

Identifiers

PMID28399797
PMCPMC5387389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.